DE69403242D1 - Cyathane Derivate und diese enthaltende Nervenwachstumsfaktor Produktion Stimulatoren und antimikrobielle Mittel - Google Patents

Cyathane Derivate und diese enthaltende Nervenwachstumsfaktor Produktion Stimulatoren und antimikrobielle Mittel

Info

Publication number
DE69403242D1
DE69403242D1 DE69403242T DE69403242T DE69403242D1 DE 69403242 D1 DE69403242 D1 DE 69403242D1 DE 69403242 T DE69403242 T DE 69403242T DE 69403242 T DE69403242 T DE 69403242T DE 69403242 D1 DE69403242 D1 DE 69403242D1
Authority
DE
Germany
Prior art keywords
nerve growth
stimulators
produce
growth factor
antimicrobial agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69403242T
Other languages
English (en)
Other versions
DE69403242T2 (de
Inventor
Hirokazu Kawagishi
Fumihiro Ojima
Kenji Okamoto
Hideki Sakamoto
Yukio Ishiguro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kagome Co Ltd
Original Assignee
Kagome Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5071251A external-priority patent/JP2657883B2/ja
Priority claimed from JP5071250A external-priority patent/JP2632121B2/ja
Priority claimed from JP5240544A external-priority patent/JP2657894B2/ja
Application filed by Kagome Co Ltd filed Critical Kagome Co Ltd
Publication of DE69403242D1 publication Critical patent/DE69403242D1/de
Application granted granted Critical
Publication of DE69403242T2 publication Critical patent/DE69403242T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
DE69403242T 1993-03-04 1994-03-03 Cyathane Derivate und diese enthaltende Nervenwachstumsfaktor Produktion Stimulatoren und antimikrobielle Mittel Expired - Lifetime DE69403242T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5071251A JP2657883B2 (ja) 1993-03-04 1993-03-04 シアタン誘導体及びこれを有効成分とする神経成長因子産生誘導剤並びに抗菌剤
JP5071250A JP2632121B2 (ja) 1993-03-04 1993-03-04 シアタン誘導体及びこれを有効成分とする神経成長因子産生誘導剤並びに抗菌剤
JP5240544A JP2657894B2 (ja) 1993-08-31 1993-08-31 シアタン誘導体及びこれを有効成分とする神経成長因子産生誘導剤並びに抗菌剤
US08/196,049 US5391544A (en) 1993-03-04 1994-02-10 Cyathane derivatives and antimicrobial agents containing same

Publications (2)

Publication Number Publication Date
DE69403242D1 true DE69403242D1 (de) 1997-06-26
DE69403242T2 DE69403242T2 (de) 1997-10-30

Family

ID=27465350

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69403242T Expired - Lifetime DE69403242T2 (de) 1993-03-04 1994-03-03 Cyathane Derivate und diese enthaltende Nervenwachstumsfaktor Produktion Stimulatoren und antimikrobielle Mittel

Country Status (5)

Country Link
US (1) US5391544A (de)
EP (1) EP0613903B1 (de)
AT (1) ATE153340T1 (de)
DE (1) DE69403242T2 (de)
ES (1) ES2104272T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565436A (en) * 1994-02-10 1996-10-15 Kagome Kabushiki Kaisha Production stimulators of nerve growth factors comprising cyathane derivatives
EP1554572B1 (de) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP3827747A1 (de) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharmainformatiksystem
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0826010B2 (ja) * 1991-03-02 1996-03-13 カゴメ株式会社 クロマン誘導体及びこれを有効成分とするｐｇｅ２産生抑制剤並びにｎｇｆ産生誘導剤

Also Published As

Publication number Publication date
ES2104272T3 (es) 1997-10-01
ATE153340T1 (de) 1997-06-15
DE69403242T2 (de) 1997-10-30
EP0613903B1 (de) 1997-05-21
EP0613903A1 (de) 1994-09-07
US5391544A (en) 1995-02-21

Similar Documents

Publication Publication Date Title
ATE165097T1 (de) Anwendung von indolocarbazol-derivaten zur behandlung von prostataerkrankungen
EP0580968A3 (de)
TW222638B (de)
DE69403242T2 (de) Cyathane Derivate und diese enthaltende Nervenwachstumsfaktor Produktion Stimulatoren und antimikrobielle Mittel
DE69307478T2 (de) Vitamin D3 Derivate
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
ES2061794T3 (es) Nuevos derivados de benzazepina.
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
GR3004095T3 (de)
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MOSELPATENT TRIERPATENT, 54290 TRIER

8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE SERWE & DR. WAGNER, 54290 TRIER